Carlos J Alméciga-Díaz Selected Research

Keratan Sulfate

7/2020	Bromocriptine as a Novel Pharmacological Chaperone for Mucopolysaccharidosis IV A.
1/2019	Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.
1/2015	Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.
12/2012	Current and emerging treatments and surgical interventions for Morquio A syndrome: a review.
9/2010	Adeno-associated virus gene transfer in Morquio A disease - effect of promoters and sulfatase-modifying factor 1.
9/2008	[Construction of an adenoassociated, viral derived, expression vector to correct the genetic defect in Morquio A disease].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos J Alméciga-Díaz Research Topics

Disease

15	Mucopolysaccharidoses 07/2020 - 09/2008
12	Mucopolysaccharidosis IV (Morquio Syndrome) 07/2020 - 09/2008
12	Lysosomal Storage Diseases (Lysosomal Storage Disease) 07/2020 - 10/2013
2	Inborn Errors Metabolism (Inborn Errors of Metabolism) 03/2020 - 07/2019
1	Candidiasis (Moniliasis) 01/2022
1	Invasive Fungal Infections 01/2022
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 12/2020
1	Osteoporosis 10/2020
1	Mucopolysaccharidosis II (Hunter Syndrome) 09/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Tay-Sachs Disease 01/2018
1	Shock 01/2017
1	Umbilical Hernia (Omphalocele) 02/2015
1	Congenital Abnormalities (Deformity) 02/2015
1	Bone Diseases (Bone Disease) 02/2015
1	Coarse facial features 02/2015
1	Infections 02/2015
1	Intellectual Disability (Idiocy) 02/2015
1	Lung Diseases (Lung Disease) 12/2012
1	Disease Progression 12/2012
1	Pathologic Constriction (Stenosis) 12/2012
1	Pneumonia (Pneumonitis) 12/2012
1	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 12/2012
1	Apnea 12/2012
1	Developmental Bone Diseases (Bone Dysplasia) 12/2012

Drug/Important Bio-Agent (IBA)

11	EnzymesIBA 07/2020 - 09/2008
8	SulfatasesIBA 07/2020 - 09/2010
6	Keratan SulfateIBA 07/2020 - 09/2008
6	GlycosaminoglycansIBA 12/2019 - 12/2012
3	Hexosaminidases (Hexosaminidase)IBA 12/2020 - 02/2016
3	Proteins (Proteins, Gene)FDA Link 03/2020 - 09/2015
2	Pharmaceutical PreparationsIBA 10/2020 - 01/2018
2	Lysergic Acid Diethylamide (LSD)IBA 02/2016 - 01/2016
1	EchinocandinsIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	AzolesIBA 01/2022
1	PolyenesIBA 01/2022
1	GangliosidesIBA 12/2020
1	Diphosphonates (Bisphosphonates)IBA 10/2020
1	OligopeptidesIBA 10/2020
1	Bromocriptine (Parlodel)FDA LinkGeneric 07/2020
1	Therapeutic UsesIBA 01/2018
1	Hexosaminidase A (Hex A)IBA 01/2018
1	Tocopherols (Tocopherol)IBA 01/2018
1	CyclodextrinsIBA 01/2018
1	LipidsIBA 01/2018
1	DisulfidesIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 02/2016
1	human GALNS proteinIBA 11/2015
1	Anesthetics (Anesthetic Agents)IBA 12/2012
1	Complementary DNA (cDNA)IBA 09/2010
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 09/2010

Therapy/Procedure

9	Therapeutics 12/2020 - 11/2010
7	Enzyme Replacement Therapy 12/2020 - 11/2010
1	Orthopedic Procedures 01/2015
1	Hematopoietic Stem Cell Transplantation 01/2015
1	Anesthesia 12/2012
1	Complementary Therapies (Alternative Medicine) 09/2008